在ST段升高心肌梗塞患者中,与左心室血栓症相关的瘤性2的可溶性抑制
Xinjia Du1, Perkash Kumar1, Chen Liu1
1Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
BMC cardiovascular disorders
|March 21, 2025
概括
可溶性抑制瘤发源性2 (sST2) 是ST段升高心肌梗塞 (STEMI) 后左心室血栓形成的独立预测因子. 这种炎症标志物改善了初级皮肤冠状动脉干预 (pPCI) 后LVT形成的风险预测模型.
科学领域:
- 心脏病学 心脏病学
- 生物标志物 生物标志物
- 炎症 炎症是一种炎症.
背景情况:
- 左心室血栓形成 (LVT) 是ST段升高心肌梗塞 (STEMI) 的并发症,与炎症有关.
- 溶性抑制瘤发源性2 (sST2) 是一种新的炎症标志物,与LVT的关联不清楚.
- 在STEMI患者的紧急穿皮冠状动脉干预 (pPCI) 后,调查sST2和LVT之间的关系至关重要.
研究的目的:
- 研究在接受pPCI的STEMI患者中sST2水平和LVT形成之间的相关性.
- 确定sST2是否是STEMI后LVT的独立预测因素.
- 评估sST2在改进LVT风险分层模型中的实用性.
主要方法:
- 招募了293名STEMI患者的队列,在入院时测量了sST2水平.
- 心脏磁共振成像 (CMR) 用于评估心肌梗塞特征和诊断 LVT.
- 用多变量逻辑回归,净重新分类指数 (NRI) 和综合歧视改善 (IDI) 来进行分析.
主要成果:
- 38名患者在STEMI后发展出LVT.
- 发现高的sST2水平是LVT形成的独立预测因素 (P = 0.002,OR = 1.01).
- 正如NRI和IDI所指出的那样,sST2显著改善了LVT的传统风险模型.
结论:
- 在STEMI患者中,sST2与pPCI后的LVT发展独立相关.
- sST2 提高了 LVT 风险建模的准确性.
- sST2可以作为一个有价值的生物标志物来预测STEMI患者的LVT.
更多相关视频
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
3.2K
05:48Left Coronary Artery Ligation: A Surgical Murine Model of Myocardial Infarction
Published on: August 9, 2022
4.1K
相关概念视频
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
